x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




AstraZeneca loses Seroquel appeal

10-05-2013

The UK Court of Appeal has upheld the High Court’s decision that AstraZeneca’s patent for a sustained release formulation of anti-psychotic drug quetiapine is invalid.


AstraZeneca, Seroquel, Hexal, drug formulation, dosage

WIPR

Payment types accepted